New CRO Focused on Cannabis-based Drug Trials Launched
Cannovation Clinical Research Partners takes a holistic approach to assist businesses throughout the entire product lifecycle, encompassing product development, commercialization, and launch phases.
May 23, 2024
by PharmaSources
CBD and Cannabis Products for Acne, Psoriasis? Buyer Beware, Dermatologists Say
Growing numbers of folks are turning to CBD or cannabis products to treat skin conditions like acne or rosacea, but researchers warn that the science on their safety and power hasn't kept up with demand.
January 17, 2022
by drugs.com
Panaxia's medical cannabis facility in Malta gains EU-GMP standard
This second facility gives the company a significant power multiplier for export capacity and geographical reach.
January 6, 2022
by CPhIonline
Cannabis Use Disorder May Be Linked to Growing Number of Heart Attacks in Younger Adults
At a time of increasing legalization of marijuana, a growing number of people under 50 diagnosed with cannabis use disorder were later hospitalized for a heart attack, new research has found.
November 9, 2021
by Drugs
$ 1.20 bn growth in Cannabis Testing Market in Life Sciences Tools & Services | Technavio Partnering with over 100 Fortune 500 Companies
The cannabis testing market in the Life Sciences Tools & Services industry is poised to grow by $ 1.20 bn during 2021-2025. Technavio's latest market research report estimates that the cannabis testing market will be progressing at a CAGR of about 13%.
September 28, 2021
by prnewswire
Cannabis Use Lower in Cancer Survivors Than General Population
Cancer survivors use cannabis at slightly lower rates than individuals without a history of cancer, according to a study published online Aug. 13 in Cancer.
August 19, 2021
by drugs
Panaxia & AxioNovo GmbH to Market Cannabis-Based Products in Germany
Panaxia Labs Israel Ltd., a pharma company that specializes in developing, manufacturing and marketing progressive medical cannabis products and the German pharmaceutical company AxioNovo GmbH, specialized in the field of Oncology, announced the ...
July 30, 2021
by americanpharmaceuticalreview
MediPharm Labs Receives Canadian GMP Pharmaceutical DEL
License can be used for manufacturing, testing and sale of APIs and pharmaceutical drug products containing cannabis.
July 16, 2021
by contractpharma
Pot Use May Change the Teenage Brain, MRIs Show
Smoking pot appears to affect teens' brain development, altering it in ways that could diminish their reasoning, decision-making and memory skills as they age, a new study reports.
June 18, 2021
by drugs
Santé Laboratories and Bioarc announce strategic partnership to accelerate product development in Australia
In a move destined to shape the global growth and evolution of the medicinal cannabinoid industry, medicinal cannabis horticultural company Bioarc Ltd. is joining forces with specialty drug development and manufacturing company Santé Laboratories to ...
May 19, 2021
by prnasia
Highest British business award goes to cannabis drug developer, GW Pharmaceuticals
The Queen’s Award for Enterprise in Innovation was awarded to GW for leadership in cannabinoid science and development of prescription cannabis-based medicines.
April 30, 2021
by europeanpharmaceuticalreview
Jazz Pharma to buy GW Pharma for $7.2 billion, adding cannabis-based drug to portfolio
The deal will allow Jazz to move beyond sleep disorders and cancer treatments by beefing up its neuroscience unit.
February 4, 2021
by expresspharma